top of page

I3LUNG

INTEGRATIVE SCIENCE, INTELLIGENT DATA PLATFORM FOR INDIVIDUALIZED LUNG CANCER CARE WITH IMMUNOTHERAPY

LUNG

6

2200

N/A

Spain, Greece, Italy, Israel, USA, Germany

Recruitment

CLINICAL TRIAL DETAILS

I3LUNG IS A EUROPEAN PROJECT FUNDED UNDER THE FRAMEWORK OF THE H2020 CALL "ENSURING ACCESS TO INNOVATIVE, SUSTAINABLE AND HIGH-QUALITY HEALTH CARE". THE PROJECT AIMS TO DEVELOP A MEDICAL DEVICE TO PREDICT IMMUNOTHERAPY EFFICACY FOR NSCLC PATIENTS THROUGH THE INTEGRATION OF MULTISOURCE DATA (REAL WORLD AND MULTI-OMICS DATA) FROM A RETROSPECTIVE AND A PROSPECTIVE PHASE. THE FINAL OBJECTIVE IS THE ESTABLISHMENT OF A WORLDWIDE DATA SHARING AND ELABORATION PLATFORM (DSEP) AND AN INDIVIDUALIZED PATIENT DECISION AID SYSTEM (iPDAS) TO SUPPORT CLINICIANS IN TREATMENT SELECTION.

TUMOR TYPE

PHASE

N

SITES

COUNTRY

STATUS

PRESS RELEASE

home_fondo_you_barra.jpg

SCIENTIFIC IMPACT

home_fondo_you_barra.jpg

BLOG ARTICLES RELATED

home_fondo_you_barra.jpg

PHERGAIN SITES

home_fondo_you_barra.jpg
Dr. Cortes and Dr. Llombart PHERain interview
Beyond Chemotherapy
Dr. Vanes Quiroga
Dr. Sofia Braga
Dr. Silvi Antolín
Dr. Escrivá de Romaní
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley
bottom of page